Healthtech Startups

Definitive Healthcare delivers market intelligence and data analytics on healthcare organizations, clinicians, and consumers, serving life sciences companies, healthcare providers, and other industries that interact with healthcare. The company provides data consolidation, analytics services, and digital advertising activation capabilities to help customers make informed decisions in the healthcare market.

1 investor

QMD manufactures single-use medical devices and precision components, specializing in silicone and elastomeric solutions for medical device OEMs. The company offers end-to-end services including engineering, regulatory affairs, quality assurance, and supply chain support.

1 investor

A physician-led urology group focused on improving outpatient, day-clinic, and inpatient urological care through a network run independently by doctors. It serves urology patients and practitioners in Germany.

1 investor

DELABO.GROUP is a network and holding company that brings together dental laboratories (Dentallabore) in Germany, providing centralized services in finance, HR, marketing, operations, and digital transformation so member labs can focus on their core business. The group has achieved market leadership in Germany through acquisition and consolidation of dental labs.

1 investor

Dele Health uses Vayyar's camera- and wearable-free sensor technology with AI to monitor residents in elderly care and senior living facilities, detecting events like falls and unusual movement patterns. It provides real-time staff alerts and data-driven insights to improve care plans, operational efficiency, and facility NOI.

1 investor

DELiver Therapeutics develops small molecule and peptide therapeutics using high-throughput DNA encoded library (DEL) drug screening to address challenging and previously "undruggable" targets in clinical medicine, with a focus on tyrosine kinase targets. Its R&D facilities are located at K2Bio in Houston.

1 investor

Deliver Biosciences develops a nanoparticle-based delivery platform to genetically engineer cells inside patients (in vivo) for cell and gene therapies, using programmable targeting to transport payloads such as DNA and mRNA to specific cell types. Its first product targets T-cells to deliver a CAR gene for cancer immunotherapy, with longer-term applications in autoimmune, neurodegenerative, and cardiovascular diseases.

1 investor

Delman offers a self-service analytics platform that generates interactive, customizable dashboards with real-time data from sales, marketing, operations, or finance datasets. It is aimed at business and data teams for reporting, forecasting, and performance monitoring, with cloud, hybrid, or on-premise deployment.

1 investor

DelNova is a life science company developing proprietary assets in medical aesthetics and neuromuscular therapeutics, having advanced from early research into Series A financing. Its work relates to injectable aesthetics such as neurotoxins and peripheral nerve applications.

1 investor

Delox develops proprietary bio-decontamination solutions using solid-formulated hydrogen peroxide technology for healthcare, pharmaceutical, laboratory, and industrial environments where contamination control is critical. The company operates across Europe and North America, serving organizations in highly controlled settings that require precision decontamination with zero tolerance for failure.

1 investor

Delphian Tx is a clinical-stage biopharmaceutical company developing cannabinoid-based drugs (CBD:THC combinations) targeting the endocannabinoid system to treat migraine and other complex pain and CNS disorders. The company has a Phase 1 clinical trial ongoing and issued USPTO patents.

1 investor

Delphi Behavioral Health Group operates a network of drug and alcohol detox and treatment centers offering personalized addiction treatment in intimate settings. The company serves individuals struggling with substance abuse, providing clinical care with low clinician-to-client ratios and aftercare services focused on relapse prevention.

1 investor

Delphinium is a boutique clinical research organization (CRO) based in Groningen, Netherlands, that conducts early-phase clinical trials with a focus on healthy volunteers across therapeutic areas including cardiology, neurology, and metabolic diseases. The company operates its own clinical research unit with 12 beds and in-house pharmacy, offering services in pharmacokinetics/pharmacodynamics, first-in-human, and bioequivalence studies.

1 investor

Deltamune manufactures registered and autogenous vaccines for poultry health, protecting birds against diseases including infectious coryza, egg drop syndrome, and salmonella infections. Operating from a GMP-certified facility in South Africa since 2008, the company serves poultry producers and veterinarians with custom vaccine solutions and commercial vaccine products.

1 investor

Delve develops molecular next-generation sequencing (mNGS) tests that diagnose infections in cerebrospinal fluid and other clinical samples, enabling rapid pathogen identification for patients with difficult-to-diagnose infections.

1 investor

DemDx develops AI-powered clinical decision support software for frontline healthcare workers, enabling nurses and practitioners to make faster, more consistent medical decisions. The platform uses machine learning to codify doctors' clinical expertise and knowledge into digital tools that improve treatment consistency while reducing pressure on healthcare systems.

1 investor

Demandforce provides software to help small businesses manage client relationships and improve operational efficiency. The platform serves small business owners looking to strengthen customer connections and reclaim time for their core business activities.

1 investor

Demeetra is a genome engineering company that develops precision gene-editing platforms — including Cas-CLOVER, Harbor-IN and Super piggyBac transposases and CleanCut CHO host cell lines — along with integrated cell line development and GMP manufacturing services. It serves biopharmaceutical developers through flexible licensing and service models for cell line development, biomanufacturing, and discovery programs.

1 investor

AACDS is an Australian Registered Training Organisation offering nationally accredited qualifications in cosmetic nursing, dermal therapies, and personal care formulation, delivered through a blend of online and clinical practical modules. Its courses serve students pursuing careers in the cosmetic medicine and aesthetics industry in Australia.

1 investor

DENCODA develops DNA-based diagnostic assays that detect enzyme activity to identify diseases including osteoarthritis, kinase-related cancers, and protease-linked conditions. The company serves clinicians, researchers, and patients seeking early disease detection and diagnosis.

1 investor

Dendi builds a modern software platform designed for clinical laboratories to improve operational efficiency and capacity. The company serves a range of medical organizations including diagnostic labs, reference labs, urgent care networks, and healthcare centers.

1 investor

DenScore offers a web-based dental navigation tool and online directories that help consumers find dental providers and insurance plans and access quality dental care. The company uses data science and machine learning to generate insights about dental care options.

1 investor

Denta embeds AI engineers into dental organizations to automate business operations and administrative processes using AI. The company serves dental practices and healthcare organizations seeking to reduce dependence on traditional software systems.

1 investor

DentalPRO is a medical information system designed for dental clinics and practices in Russia. It provides inventory management, treatment planning, electronic medical records, financial controls, CRM, and analytics to help dental practices streamline operations and increase revenue.

1 investor